HomeCompareHYMCZ vs PFE

HYMCZ vs PFE: Dividend Comparison 2026

HYMCZ yields 5714.29% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HYMCZ wins by $228153224412509.53M in total portfolio value
10 years
HYMCZ
HYMCZ
● Live price
5714.29%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$228153224412509.59M
Annual income
$220,560,399,839,122,060,000.00
Full HYMCZ calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — HYMCZ vs PFE

📍 HYMCZ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHYMCZPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HYMCZ + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HYMCZ pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HYMCZ
Annual income on $10K today (after 15% tax)
$485,714.29/yr
After 10yr DRIP, annual income (after tax)
$187,476,339,863,253,750,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, HYMCZ beats the other by $187,476,339,863,253,700,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HYMCZ + PFE for your $10,000?

HYMCZ: 50%PFE: 50%
100% PFE50/50100% HYMCZ
Portfolio after 10yr
$114076612206254.83M
Annual income
$110,280,199,919,561,050,000.00/yr
Blended yield
96.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

HYMCZ
No analyst data
Altman Z
-4.1
Piotroski
2/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HYMCZ buys
0
PFE buys
0
No recent congressional trades found for HYMCZ or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHYMCZPFE
Forward yield5714.29%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$228153224412509.59M$49.6K
Annual income after 10y$220,560,399,839,122,060,000.00$26,258.71
Total dividends collected$227641622319776.13M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HYMCZ vs PFE ($10,000, DRIP)

YearHYMCZ PortfolioHYMCZ Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$582,129$571,428.57$9,153$693.39+$573.0KHYMCZ
2$31,711,186$31,088,308.22$8,593$849.25+$31.70MHYMCZ
3$1,616,661,128$1,582,730,159.44$8,336$1,066.78+$1616.65MHYMCZ
4$77,139,944,357$75,410,116,950.20$8,437$1,384.80+$77139.94MHYMCZ
5$3,445,379,409,484$3,362,839,669,021.90$9,013$1,875.40+$3445379.40MHYMCZ
6$144,058,436,084,716$140,371,880,116,567.28$10,306$2,680.72+$144058436.07MHYMCZ
7$5,639,412,164,337,400$5,485,269,637,726,755.00$12,820$4,101.38+$5639412164.32MHYMCZ
8$206,716,597,857,094,600$200,682,426,841,253,570.00$17,673$6,826.70+$206716597857.08MHYMCZ
9$7,096,097,732,137,874,000$6,874,910,972,430,782,000.00$27,543$12,591.86+$7096097732137.85MHYMCZ
10$228,153,224,412,509,600,000$220,560,399,839,122,060,000.00$49,560$26,258.71+$228153224412509.53MHYMCZ

HYMCZ vs PFE: Complete Analysis 2026

HYMCZStock

Hycroft Mining Holding Corporation, together with its subsidiaries, operates as a gold and silver development company in the United States. The company holds interests in the Hycroft mine that covers an area of approximately 70,671 acres located in the state of Nevada. As of December 31, 2021, its Hycroft mine had measured and indicated mineral resources of 9.6 million ounces of gold, and 446.0 million ounces of silver. Hycroft Mining Holding Corporation is headquartered in Winnemucca, Nevada.

Full HYMCZ Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this HYMCZ vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HYMCZ vs SCHDHYMCZ vs JEPIHYMCZ vs OHYMCZ vs KOHYMCZ vs MAINHYMCZ vs JNJHYMCZ vs MRKHYMCZ vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.